| scholarly article | Q13442814 |
| P50 | author | D. Neil Hayes | Q42678349 |
| Ignacio I Wistuba | Q74766086 | ||
| P2093 | author name string | Baili Zhang | |
| Ralf Krahe | |||
| Jennifer Churchill | |||
| Keith A Baggerly | |||
| Kristy L Richards | |||
| Charmaine D Wilson | |||
| Guosheng Yin | |||
| Linda L Bachinski | |||
| Menghong Sun | |||
| Wenli Dong | |||
| P2860 | cites work | miRBase: microRNA sequences, targets and gene nomenclature | Q24538656 |
| Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. | Q24538785 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| The epithelial-mesenchymal transition: new insights in signaling, development, and disease | Q24683758 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites | Q28187720 | ||
| A gene hypermethylation profile of human cancer | Q28213253 | ||
| Revisions in the International System for Staging Lung Cancer | Q28241070 | ||
| Methylation profiling of archived non-small cell lung cancer: a promising prognostic system | Q28256841 | ||
| Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 | Q28294917 | ||
| The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis | Q28504626 | ||
| Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers | Q29615475 | ||
| Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force | Q31057585 | ||
| Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial | Q34271566 | ||
| Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter | Q34323096 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Genome-wide promoter analysis uncovers portions of the cancer methylome. | Q35008027 | ||
| Gene-promoter hypermethylation as a biomarker in lung cancer | Q35877182 | ||
| Screening for lung cancer: New horizons? | Q36175012 | ||
| Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer | Q36791714 | ||
| The impact of genetic markers on the diagnosis of lung cancer: a current perspective | Q36988107 | ||
| Epigenetics of cancer progression | Q37120846 | ||
| Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay | Q37389505 | ||
| Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. | Q40002585 | ||
| Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma | Q44813445 | ||
| EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients | Q46685665 | ||
| Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung | Q46780243 | ||
| Methylated genes as new cancer biomarkers. | Q55465448 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 606-617 | |
| P577 | publication date | 2010-10-13 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers | |
| P478 | volume | 117 |
| Q57125214 | A network-based signature to predict the survival of non-smoking lung adenocarcinoma |
| Q38613802 | A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification |
| Q58613614 | Adaptively capturing the heterogeneity of expression for cancer biomarker identification |
| Q54979352 | Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. |
| Q34534982 | Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma |
| Q34479335 | Clinicopathological significance and biological role of TCF21 mRNA in breast cancer |
| Q35133698 | Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation |
| Q37699374 | Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer |
| Q97094004 | Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma |
| Q34846044 | Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus |
| Q39373653 | Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine). |
| Q55717061 | Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma. |
| Q47129993 | Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer |
| Q55263360 | Hypermethylation of protocadherin γ subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer. |
| Q35859326 | IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscle |
| Q91755842 | Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma |
| Q36189699 | Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma |
| Q64116711 | MicroRNA-3648 Is Upregulated to Suppress TCF21, Resulting in Promotion of Invasion and Metastasis of Human Bladder Cancer |
| Q38124776 | Molecular biomarkers for future screening of lung cancer |
| Q55396475 | Multiple biological functions of transcription factor 21 in the development of various cancers. |
| Q33700571 | Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma. |
| Q55334108 | Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer. |
| Q91940161 | Promoter methylation of the candidate tumor suppressor gene TCF21 in myelodysplastic syndrome and acute myeloid leukemia |
| Q54193729 | Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer. |
| Q86490397 | Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma |
| Q37274578 | Research status and funding trends of lung cancer biomarkers |
| Q43210374 | Screening feature genes of lung carcinoma with DNA microarray analysis |
| Q39100963 | Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). |
| Q37295632 | Sumoylation of TCF21 downregulates the transcriptional activity of estrogen receptor-alpha |
| Q37712367 | TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling |
| Q89538752 | The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer |
| Q36744048 | The Lhx9-integrin pathway is essential for positioning of the proepicardial organ |
| Q30317739 | The role of DNA methylation as biomarkers in the clinical management of lung cancer |
| Q37044593 | The state of molecular biomarkers for the early detection of lung cancer |
| Q58095875 | Transcription Factor 21 Is Required for Branching Morphogenesis and Regulates the Gdnf-Axis in Kidney Development |
| Q55451366 | [Effects of tumor suppressor gene TCF21 on the proliferation, migration and apoptosis of A549 cells]. |
Search more.